Cargando…

Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trials

Direct oral anticoagulants (DOACs) may be good alternatives to low molecular weight heparin (LMWH) or vitamin K antagonists (VKA) for treatment of cancer associated thrombosis (CAT). We conducted a meta-analysis of ten randomized clinical trials to evaluate the efficacy and safety of DOACs in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desai, Ruchi, Koipallil, Gautam Krishna, Thomas, Nelson, Mhaskar, Rahul, Visweshwar, Nathan, Laber, Damian, Patel, Ankita, Jaglal, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642281/ https://www.ncbi.nlm.nih.gov/pubmed/33144679 http://dx.doi.org/10.1038/s41598-020-75863-3

Ejemplares similares

Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution
por: Logothetis, Constantine N., et al.
Publicado: (2021)

AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy—with large granular lymphocytic leukemia
por: Visweshwar, Nathan, et al.
Publicado: (2016)

Evolving paradigm in thrombophilia screening
por: Ashraf, Noman, et al.
Publicado: (2019)

Primary immune thrombocytopenia: a ‘diagnosis of exclusion’?
por: Visweshwar, Nathan, et al.
Publicado: (2022)

Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathy
por: Sandoval-Sus, Jose D., et al.
Publicado: (2017)

Insights into the Impact of Hesitancy on Cancer Care and COVID-19
por: Visweshwar, Nathan, et al.
Publicado: (2023)

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
por: Zakai, Neil A., et al.
Publicado: (2021)

Cancer‐associated thrombosis: Role of direct oral anticoagulants
por: Ikeda, Masataka, et al.
Publicado: (2018)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
por: Al-Samkari, Hanny, et al.
Publicado: (2018)

Postoperative Ovarian Vein Thrombosis and Treatment with Direct Oral Anticoagulant
por: Shukr, Ghadear, et al.
Publicado: (2023)

Hematological Malignancies and Arterial Thromboembolism
por: Visweshwar, Nathan, et al.
Publicado: (2019)

Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
por: Wilks, Mailey L.
Publicado: (2022)

Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis
por: Attard, Laura M, et al.
Publicado: (2022)

Anticoagulation With Platelet Transfusions for Acute Limb Ischemia With Severe Thrombocytopenia
por: Shakfeh, Khalid, et al.
Publicado: (2023)

Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants
por: Reda, Sara, et al.
Publicado: (2020)

Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis
por: Montiel, Francisco Sánchez, et al.
Publicado: (2017)

Direct oral anticoagulants for treatment of deep vein thrombosis: overview of systematic reviews
por: Brandão, Gustavo Muçouçah Sampaio, et al.
Publicado: (2018)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review
por: Bose, Gauruv, et al.
Publicado: (2021)

The Role of Direct Oral Anticoagulants in Cancer-Associated Thrombosis According to the Current Literature
por: Nana, Petroula, et al.
Publicado: (2021)

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021)

Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art
por: Monaco, Giovanni, et al.
Publicado: (2023)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol
por: Bose, Gauruv, et al.
Publicado: (2019)

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
por: Fedorov, Kateryna, et al.
Publicado: (2021)

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
por: Biolato, Marco, et al.
Publicado: (2022)

Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?
por: Ramacciotti, Eduardo, et al.
Publicado: (2019)

Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
por: Park, Jiesuck, et al.
Publicado: (2019)

Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
por: Carré, Julie, et al.
Publicado: (2021)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Efficacy and Safety of Direct-Acting Oral Anticoagulants Use in Acute Portal Vein Thrombosis Unrelated to Cirrhosis
por: Nery, Filipe, et al.
Publicado: (2017)

Case report: A case of renal arcuate vein thrombosis successfully treated with direct oral anticoagulants
por: Torabi Jahromi, Mahsa, et al.
Publicado: (2023)

Direct oral anticoagulants for the treatment of cerebral venous thrombosis – a protocol of an international phase IV study
por: van de Munckhof, Anita, et al.
Publicado: (2023)

Frequency of Thrombosis in Covid-19 Patients Compared to Non-Covid-19 Sepsis Patients Admitted to the Intensive Care Unit
por: Huang, Sherri, et al.
Publicado: (2022)

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature
por: Watras, Magdalena M., et al.
Publicado: (2016)

Anticoagulant Therapy in Thrombosis
por: Jorpes, J. Erik
Publicado: (1946)

Cannot write session to /tmp/vufind_sessions/sess_dle99v781d8amfsi1tcc0ms78a